Brickell Historical Income Statement

BBI
 Stock
  

USD 3.36  0.09  2.75%   

Historical analysis of Brickell Biotech income statement accounts such as Cost of Revenue of 7.3 M, Gross Profit of 414.6 K or Interest Expense of 63.7 K can show how well Brickell Biotech performed in making a profits. Evaluating Brickell Biotech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Brickell Biotech's future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Brickell Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Brickell Biotech is a good buy for the upcoming year.
Continue to Trending Equities.
  

About Brickell Income Statement Analysis

Brickell Biotech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Brickell Biotech shareholders. The income statement also shows Brickell investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Brickell Biotech Income Statement Chart

Brickell Biotech Income Statement is one of the three primary financial statements used for reporting Brickell's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Brickell Biotech revenue and expense. Brickell Biotech Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Brickell Biotech Gross Profit is most likely to decrease significantly in the upcoming years. The last year's value of Gross Profit was reported at 404,000. The current Interest Expense is estimated to increase to about 63.7 K, while Consolidated Income is projected to decrease to (40.5 M).

Earning Before Interest and Taxes EBIT

Earnings Before Interest and Tax is calculated by adding [TaxExp] and Interest Expense back to Net Income.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Brickell Biotech financial statement analysis. It represents the amount of money remaining after all of Brickell Biotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends Income Statement Impact.

Revenues

Revenues refers to the total amount of money received by Brickell Biotech for goods sold or services provided during a certain time period. It also includes all of Brickell Biotech sales as well as any other increase in Brickell Biotech equity.Revenues are reported on Brickell Biotech income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
Most accounts from Brickell Biotech income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Brickell Biotech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Brickell Biotech Gross Profit is most likely to decrease significantly in the upcoming years. The last year's value of Gross Profit was reported at 404,000. The current Interest Expense is estimated to increase to about 63.7 K, while Consolidated Income is projected to decrease to (40.5 M).
 2019 2020 2021 2022 (projected)
Revenues USD7.92 M1.82 M404 K414.63 K
Revenues7.92 M1.82 M404 K414.63 K

Brickell Biotech income statement Correlations

Brickell Biotech Account Relationship Matchups

Brickell Biotech income statement Accounts

201720182019202020212022 (projected)
Direct Expenses10.93 M6.29 M6.48 M1.44 M1.65 M1.69 M
Consolidated Income(12.96 M)(9.24 M)(23.88 M)(20.91 M)(39.47 M)(40.51 M)
Earning Before Interest and Taxes EBIT(12.96 M)(8.15 M)(21.78 M)(20.91 M)(39.41 M)(40.44 M)
Earning Before Interest and Taxes USD(12.96 M)(8.15 M)(21.78 M)(20.91 M)(39.41 M)(40.44 M)
Gross Profit7.34 M10.89 M7.92 M1.82 M404 K414.63 K
Net Income(12.96 M)(9.24 M)(23.88 M)(20.91 M)(39.47 M)(40.51 M)
Net Income Common Stock(12.96 M)(15.17 M)(13.6 M)(20.91 M)(39.47 M)(40.51 M)
Net Income Common Stock USD(12.96 M)(15.17 M)(13.6 M)(20.91 M)(39.47 M)(40.51 M)
Operating Expenses20.73 M19.34 M32.38 M22.8 M40.65 M35.9 M
Operating Income(13.39 M)(8.45 M)(24.47 M)(20.98 M)(40.24 M)(41.3 M)
Revenues13.82 M10.89 M7.92 M1.82 M404 K414.63 K
Revenues USD13.82 M10.89 M7.92 M1.82 M404 K414.63 K
Research and Development Expense14.39 M12.96 M20.21 M11.22 M28.23 M23.79 M
Selling General and Administrative Expense6.33 M6.38 M12.17 M11.58 M12.42 M12.11 M
Weighted Average Shares40.91 K13.04 K67.18 K544.75 K1.78 M1.93 M
Weighted Average Shares Diluted40.91 K13.04 K67.18 K544.75 K1.78 M1.93 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Brickell Biotech without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Pair Trading with Brickell Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving together with Brickell Biotech

0.69AGTCApplied Genetic Tech Fiscal Year End 22nd of September 2022 PairCorr

Moving against Brickell Biotech

0.91AGLAgilon Health Downward RallyPairCorr
0.81AVXLAnavex Lf SC Fiscal Year End 23rd of November 2022 PairCorr
0.79ARWRArrowhead Pharma Fiscal Year End 28th of November 2022 PairCorr
0.75AXSMAxsome Thera TrendingPairCorr
The ability to find closely correlated positions to Brickell Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brickell Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brickell Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brickell Biotech to buy it.
The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brickell Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brickell Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brickell Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
8.9 M
Quarterly Revenue Growth YOY
4.41
Return On Assets
-0.85
Return On Equity
-1.76
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Brickell Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.